Accenture cuts FY26 outlook as analysts lower targets

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Accenture reported Q3 earnings of $3.80 per share, beating estimates, on revenue of $18.72 billion, which missed expectations. The company narrowed its FY26 revenue outlook to $71.763 billion-$72.460 billion and raised its adjusted EPS guidance. Analysts, including those at Morgan Stanley and Guggenheim, reduced price targets in response to the weaker outlook.

powered bylight_fuzz_icon
43150677

*this image is generated using AI for illustrative purposes only.

Accenture plc shares fell on Thursday after the company reported fiscal third-quarter 2026 results that beat earnings estimates but missed revenue expectations and issued a weaker-than-expected revenue outlook. The company narrowed its full-year revenue guidance, reflecting investor concerns over the growth trajectory despite bottom-line performance.

Accenture reported third-quarter earnings of $3.80 per share, exceeding analysts' estimates of $3.69. Revenue rose 6% year over year in U.S. dollars, or 3% in local currency, to $18.72 billion, slightly below the consensus estimate of $18.75 billion. For fiscal 2026, the company narrowed its revenue guidance to $71.763 billion to $72.460 billion from its previous range of $71.763 billion to $73.157 billion. The updated outlook fell below analysts’ estimate of $74.006 billion.

The company increased its adjusted earnings forecast to $13.78 to $13.90 per share from $13.65 to $13.90. Analysts expect adjusted earnings of $13.85 per share. For the fiscal fourth quarter, Accenture expects revenue of $17.75 billion to $18.40 billion, compared with analysts’ estimate of $18.47 billion.

Analyst Expectations and Price Targets

Following the earnings announcement, several analysts adjusted their price targets downward.

Brokerage Analyst Rating Price Forecast ($)
Morgan Stanley James Faucette Equal-Weight 130.00
Guggenheim Jonathan Lee Buy 185.00
JPMorgan Tien-Tsin Huang Overweight 201.00
Wells Fargo Jason Kupferberg Overweight 248.00
Goldman Sachs James Schneider Buy 270.00
Stifel David Grossman Buy 270.00
TD Cowen Bryan Bergin Buy 258.00

Recent Corporate Developments

On June 8, Accenture agreed to acquire Whalar, a leading creator and social agency, from Whalar Group. This acquisition follows an earlier announcement where Unilever PLC said it is expanding its partnership with Accenture to scale AI-enabled digital twins across its global manufacturing network. Unilever plans to build more than 40 new digital twins over the next 18 months to improve product quality, boost efficiency, and speed up production decisions.

Technical Analysis

The longer-term trend for Accenture remains bearish. The stock trades below its key simple moving averages (SMAs), sitting 6.1% below its 20-day SMA, 7.8% below its 50-day SMA, 16.8% below its 100-day SMA, and 26.8% below its 200-day SMA. The 20-day SMA remains below the 50-day SMA, while the 50-day SMA sits below the 200-day SMA, indicating persistent selling pressure. Momentum remains weak, with the MACD sitting below its signal line and the histogram remaining negative. Immediate resistance stands at $184.50, while support is seen near $156.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the recent acquisition of Whalar specifically contribute to reversing the current revenue growth slowdown?

What impact will the expanded Unilever partnership have on Accenture's AI-driven service revenue in the next 18 months?

Will the persistent bearish technical trend and downward analyst revisions trigger further institutional selling in the near term?

like19
dislike

Accenture acquires IndX and Alfahealth to boost capabilities

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Accenture has agreed to acquire Industries eXcellence Group (IndX) and Alfahealth from Engineering Group to strengthen its Siemens Digital Industries and healthcare capabilities. The IndX acquisition adds over 650 professionals and focuses on manufacturing modernization, while the Alfahealth deal adds 1,200 professionals to Accenture Italy's Health practice. Accenture plans to establish new Centers of Excellence in Italy and India, with terms of the transactions remaining undisclosed.

powered bylight_fuzz_icon
43228438

*this image is generated using AI for illustrative purposes only.

Accenture has agreed to acquire two businesses from Engineering Group: Industries eXcellence Group (IndX) and Alfahealth. These acquisitions are designed to strengthen Accenture's capabilities in Siemens Digital Industries solutions and expand its digital health platform in Italy. The moves come as Accenture prepares to report its fiscal third-quarter earnings on June 18, 2026.

The acquisition of IndX will bolster the Accenture Siemens Business Group, enhancing its ability to help manufacturers modernize product development, production, and supply chain operations through software, data, and AI-enabled technologies. IndX specializes in implementing digital thread solutions that connect engineering, manufacturing, and automation across IT and operational technology. Its expertise spans product lifecycle management, simulation, digital twins, Supervisory Control and Data Acquisition (SCADA), industrial edge computing, and cloud computing.

Simultaneously, the acquisition of Alfahealth will expand Accenture's healthcare practice in Italy. Alfahealth provides a digital health platform focused on clinical processes, connected care data, patient access, and operational workflows. This addition is expected to significantly enhance Accenture's Health practice in the region.

Strategic Expansion and Talent Integration

The deals collectively add a significant number of professionals to Accenture's workforce. IndX contributes more than 650 professionals based in Italy, the US, India, Germany, other European countries, and Mexico. Alfahealth adds approximately 1,200 professionals to Accenture Italy's Health practice. Following the completion of the IndX acquisition, Accenture plans to establish two new Centers of Excellence for Siemens Digital Industries solutions in Italy and India.

Accenture will integrate IndX's assets and services for other technologies into its respective business units. The new Centers of Excellence will bring together professionals with expertise in industrial software and advanced digital technologies. These centers aim to help clients improve product design, factory operations, and supply chain management by combining industrial software, AI, and digital engineering capabilities.

Transaction and Market Overview

Aspect Details
Acquirer Accenture
Targets Industries eXcellence Group (IndX), Alfahealth
Parent Company Engineering Group
IndX Team Size More than 650 professionals
Alfahealth Team Size About 1,200 professionals
New Centers of Excellence Italy and India (Siemens DI)

Terms of both transactions were not disclosed. Completion of the acquisitions is subject to customary closing conditions. Accenture shares traded slightly lower in premarket session following the announcement. Analysts estimate earnings per share of $3.71 and revenue of $18.76 Billion for the upcoming quarter.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the integration of IndX's digital thread solutions impact Accenture's competitive positioning in the global manufacturing market?

What are the expected revenue synergies from combining Alfahealth's platform with Accenture's existing healthcare practice in Italy?

How will the establishment of Centers of Excellence in Italy and India influence Accenture's delivery capabilities for Siemens Digital Industries solutions?

like20
dislike

More News on Accenture - Class A